US Broker Ratings

Organon & Co. (OGN) Stock Analysis: Unpacking the 57.89% Potential Upside for Healthcare Investors

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, focuses on providing women’s health solutions and a range of pharmaceutical products across the globe. With a market..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 30% Upside Potential

LivaNova PLC (LIVN), a pioneering name in the healthcare sector, operates within the medical devices industry and is headquartered in London, United Kingdom. With a market capitalization of $3.35 billion,..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: Unveiling a 40% Potential Upside in a Promising Biotech Sector

For investors with an appetite for high-growth opportunities in the biotechnology sector, Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) presents an intriguing prospect. With a market capitalization of $8.07 billion, the company..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 54% Potential Upside

Ardent Health, Inc. (ARDT), a key player in the healthcare sector, operates within the medical care facilities industry in the United States. With a market capitalization of $1.18 billion, the..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 31.78% Potential Upside Amidst Strategic Collaborations

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, has captured investor attention with its compelling market dynamics and promising pipeline of treatments for rare disorders. With..

Sotera Health Company (SHC) Stock Analysis: Exploring a 56.60% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC) stands as a formidable entity within the healthcare sector, specializing in diagnostics and research. With a market capitalization of $3.77 billion, it has carved out..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a Potential 43% Upside

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector, has captured investor attention with its innovative approach to eyewear retailing. With a market capitalization of $2.49 billion,..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Market Dynamics with a Potential 18% Upside

Envista Holdings Corporation (NYSE: NVST), a key player in the healthcare sector, particularly within the medical instruments and supplies industry, offers a compelling case for investors looking to tap into..

Metsera, Inc. (MTSR) Stock Analysis: Navigating a Pioneering Path in Biotechnology with a -19.15% Potential Downside

Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biotechnology firm based in New York, is carving a niche in the healthcare sector with its innovative hormone analog peptides aimed at treating obesity..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring Its 171.76% Potential Upside

Ultragenyx Pharmaceutical Inc. (RARE), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 171.76%. Specializing in the development and commercialization of treatments for..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Healthcare Innovator with a 47% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the biotechnology sector as a leader in the development of innovative muscle activators and inhibitors aimed at tackling severe diseases. With a market..

ADMA Biologics Inc (ADMA) Stock Analysis: A 154% Potential Upside Opportunity in Biotech

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company, is garnering significant attention from investors due to its promising outlook in the biotechnology sector. Headquartered in Ramsey, New Jersey, ADMA focuses..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 27.96% Potential Upside in the Biotech Space

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector with its robust pipeline of genetic medicines aimed at addressing diseases with high unmet medical needs. Based in..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A Compelling 32.56% Upside Potential for Investors

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out as a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 54.40% Potential Upside in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) stands at the forefront of the precision oncology sector, offering innovative liquid biopsy tests and data solutions that are reshaping the landscape of cancer diagnostics..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Waters with an 8.42% Upside Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a notable player in the biotechnology sector, specializing in the development of RNA-targeted therapeutics and gene therapy solutions for rare diseases. With a..

Charles River Laboratories Inte (CRL) Stock Analysis: A Deep Dive into a 25% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a notable player within the Healthcare sector, more specifically in the Diagnostics & Research industry. With its headquarters in Wilmington, Massachusetts,..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR) presents an intriguing opportunity for investors in the burgeoning healthcare sector. As a prominent player in the medical devices industry, Integer Holdings boasts a market..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Exploring a 22% Upside Potential in the Biotech Sector

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the healthcare sector, specifically within the biotechnology industry, is capturing the attention of investors with its promising upside potential. With a..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: 22.71% Potential Upside for This Healthcare Innovator

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, specializes in the development and commercialization of diagnostic and therapeutic products. With a market capitalization of $4.85 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds